Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace
Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to revi...
Gespeichert in:
Veröffentlicht in: | American journal of rhinology & allergy 2010-07, Vol.24 (4), p.249-254 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 254 |
---|---|
container_issue | 4 |
container_start_page | 249 |
container_title | American journal of rhinology & allergy |
container_volume | 24 |
creator | Marple, Bradley F |
description | Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease.
MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx.
Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion.
Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions. |
doi_str_mv | 10.2500/ajra.2010.24.3499 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754020597</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754020597</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</originalsourceid><addsrcrecordid>eNo9kDtPwzAQxy0EolD4ACwoG1PK2bHjmK2qeEmVWGBisC6OQ13lUWxXVb89iVo63Z3-D-l-hNxRmDEB8IhrjzMG48lnGVfqjFxRxUVaqIydn3bGJ-Q6hDVAzgWnl2TCoBi0HK7I97xprP9xJvEr17noQoJdlbiubrBtMfZ-n6DzO9wnlQsWg30axGg9muj6LiQ7F4dgElc22XaudrYa_WGDxt6QixqbYG-Pc0q-Xp4_F2_p8uP1fTFfpibL85iWCkEKUxjJClkYrCWApFDSjAsrC8kGVVRcyVIyWanhXY48F7SUOTBGZTYlD4feje9_tzZE3bpgbNNgZ_tt0FJwYCDU6KQHp_F9CN7WeuNdi36vKegRqR6R6hGpZlyPSIfM_bF9W7a2OiX-GWZ_Rt1yLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754020597</pqid></control><display><type>article</type><title>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Marple, Bradley F</creator><creatorcontrib>Marple, Bradley F</creatorcontrib><description>Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease.
MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx.
Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion.
Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions.</description><identifier>ISSN: 1945-8924</identifier><identifier>EISSN: 1945-8932</identifier><identifier>DOI: 10.2500/ajra.2010.24.3499</identifier><identifier>PMID: 20819460</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Asthma - drug therapy ; Asthma - epidemiology ; Asthma - immunology ; Bronchi - drug effects ; Bronchi - immunology ; Cell Communication ; Clinical Trials as Topic ; Comorbidity ; Humans ; Inflammation ; Paranasal Sinuses - drug effects ; Paranasal Sinuses - immunology ; Prevalence ; Respiratory System - drug effects ; Respiratory System - immunology ; Respiratory System - metabolism ; Respiratory System - pathology ; Rhinitis, Allergic, Perennial - drug therapy ; Rhinitis, Allergic, Perennial - epidemiology ; Rhinitis, Allergic, Perennial - immunology ; Rhinitis, Allergic, Seasonal - diagnosis ; Rhinitis, Allergic, Seasonal - drug therapy ; Rhinitis, Allergic, Seasonal - epidemiology ; Rhinitis, Allergic, Seasonal - immunology ; Risk Factors</subject><ispartof>American journal of rhinology & allergy, 2010-07, Vol.24 (4), p.249-254</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</citedby><cites>FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20819460$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marple, Bradley F</creatorcontrib><title>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</title><title>American journal of rhinology & allergy</title><addtitle>Am J Rhinol Allergy</addtitle><description>Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease.
MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx.
Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion.
Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Asthma - drug therapy</subject><subject>Asthma - epidemiology</subject><subject>Asthma - immunology</subject><subject>Bronchi - drug effects</subject><subject>Bronchi - immunology</subject><subject>Cell Communication</subject><subject>Clinical Trials as Topic</subject><subject>Comorbidity</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Paranasal Sinuses - drug effects</subject><subject>Paranasal Sinuses - immunology</subject><subject>Prevalence</subject><subject>Respiratory System - drug effects</subject><subject>Respiratory System - immunology</subject><subject>Respiratory System - metabolism</subject><subject>Respiratory System - pathology</subject><subject>Rhinitis, Allergic, Perennial - drug therapy</subject><subject>Rhinitis, Allergic, Perennial - epidemiology</subject><subject>Rhinitis, Allergic, Perennial - immunology</subject><subject>Rhinitis, Allergic, Seasonal - diagnosis</subject><subject>Rhinitis, Allergic, Seasonal - drug therapy</subject><subject>Rhinitis, Allergic, Seasonal - epidemiology</subject><subject>Rhinitis, Allergic, Seasonal - immunology</subject><subject>Risk Factors</subject><issn>1945-8924</issn><issn>1945-8932</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAQxy0EolD4ACwoG1PK2bHjmK2qeEmVWGBisC6OQ13lUWxXVb89iVo63Z3-D-l-hNxRmDEB8IhrjzMG48lnGVfqjFxRxUVaqIydn3bGJ-Q6hDVAzgWnl2TCoBi0HK7I97xprP9xJvEr17noQoJdlbiubrBtMfZ-n6DzO9wnlQsWg30axGg9muj6LiQ7F4dgElc22XaudrYa_WGDxt6QixqbYG-Pc0q-Xp4_F2_p8uP1fTFfpibL85iWCkEKUxjJClkYrCWApFDSjAsrC8kGVVRcyVIyWanhXY48F7SUOTBGZTYlD4feje9_tzZE3bpgbNNgZ_tt0FJwYCDU6KQHp_F9CN7WeuNdi36vKegRqR6R6hGpZlyPSIfM_bF9W7a2OiX-GWZ_Rt1yLA</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Marple, Bradley F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201007</creationdate><title>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</title><author>Marple, Bradley F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Asthma - drug therapy</topic><topic>Asthma - epidemiology</topic><topic>Asthma - immunology</topic><topic>Bronchi - drug effects</topic><topic>Bronchi - immunology</topic><topic>Cell Communication</topic><topic>Clinical Trials as Topic</topic><topic>Comorbidity</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Paranasal Sinuses - drug effects</topic><topic>Paranasal Sinuses - immunology</topic><topic>Prevalence</topic><topic>Respiratory System - drug effects</topic><topic>Respiratory System - immunology</topic><topic>Respiratory System - metabolism</topic><topic>Respiratory System - pathology</topic><topic>Rhinitis, Allergic, Perennial - drug therapy</topic><topic>Rhinitis, Allergic, Perennial - epidemiology</topic><topic>Rhinitis, Allergic, Perennial - immunology</topic><topic>Rhinitis, Allergic, Seasonal - diagnosis</topic><topic>Rhinitis, Allergic, Seasonal - drug therapy</topic><topic>Rhinitis, Allergic, Seasonal - epidemiology</topic><topic>Rhinitis, Allergic, Seasonal - immunology</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marple, Bradley F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of rhinology & allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marple, Bradley F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</atitle><jtitle>American journal of rhinology & allergy</jtitle><addtitle>Am J Rhinol Allergy</addtitle><date>2010-07</date><risdate>2010</risdate><volume>24</volume><issue>4</issue><spage>249</spage><epage>254</epage><pages>249-254</pages><issn>1945-8924</issn><eissn>1945-8932</eissn><abstract>Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease.
MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx.
Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion.
Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions.</abstract><cop>United States</cop><pmid>20819460</pmid><doi>10.2500/ajra.2010.24.3499</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1945-8924 |
ispartof | American journal of rhinology & allergy, 2010-07, Vol.24 (4), p.249-254 |
issn | 1945-8924 1945-8932 |
language | eng |
recordid | cdi_proquest_miscellaneous_754020597 |
source | Access via SAGE; MEDLINE |
subjects | Adrenal Cortex Hormones - therapeutic use Anti-Inflammatory Agents - therapeutic use Asthma - drug therapy Asthma - epidemiology Asthma - immunology Bronchi - drug effects Bronchi - immunology Cell Communication Clinical Trials as Topic Comorbidity Humans Inflammation Paranasal Sinuses - drug effects Paranasal Sinuses - immunology Prevalence Respiratory System - drug effects Respiratory System - immunology Respiratory System - metabolism Respiratory System - pathology Rhinitis, Allergic, Perennial - drug therapy Rhinitis, Allergic, Perennial - epidemiology Rhinitis, Allergic, Perennial - immunology Rhinitis, Allergic, Seasonal - diagnosis Rhinitis, Allergic, Seasonal - drug therapy Rhinitis, Allergic, Seasonal - epidemiology Rhinitis, Allergic, Seasonal - immunology Risk Factors |
title | Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A45%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allergic%20rhinitis%20and%20inflammatory%20airway%20disease:%20interactions%20within%20the%20unified%20airspace&rft.jtitle=American%20journal%20of%20rhinology%20&%20allergy&rft.au=Marple,%20Bradley%20F&rft.date=2010-07&rft.volume=24&rft.issue=4&rft.spage=249&rft.epage=254&rft.pages=249-254&rft.issn=1945-8924&rft.eissn=1945-8932&rft_id=info:doi/10.2500/ajra.2010.24.3499&rft_dat=%3Cproquest_cross%3E754020597%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=754020597&rft_id=info:pmid/20819460&rfr_iscdi=true |